ROYAL BANK OF CANADA - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 52 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$02,5040.0%0.00%
Q4 2018$0
-100.0%
2,5040.0%0.00%
Q3 2018$1,0000.0%2,5040.0%0.00%
Q2 2018$1,0000.0%2,504
-3.8%
0.00%
Q1 2018$1,000
-50.0%
2,604
-61.2%
0.00%
Q4 2017$2,000
-50.0%
6,704
-37.4%
0.00%
Q3 2017$4,000
-20.0%
10,704
+0.8%
0.00%
Q2 2017$5,000
-16.7%
10,623
+0.2%
0.00%
Q1 2017$6,000
-14.3%
10,6000.0%0.00%
Q4 2016$7,000
-30.0%
10,6000.0%0.00%
Q3 2016$10,000
+66.7%
10,6000.0%0.00%
Q2 2016$6,000
-40.0%
10,6000.0%0.00%
Q1 2016$10,000
-91.5%
10,600
-88.0%
0.00%
Q4 2015$118,000
+195.0%
88,345
+400.8%
0.00%
Q3 2015$40,000
+25.0%
17,642
-10.2%
0.00%
Q2 2015$32,000
+6.7%
19,651
+3.2%
0.00%
Q1 2015$30,000
+50.0%
19,039
+79.6%
0.00%
Q4 2014$20,000
+81.8%
10,600
+23.3%
0.00%
Q3 2014$11,000
-15.4%
8,600
-2.3%
0.00%
Q2 2014$13,000
-64.9%
8,800
-55.6%
0.00%
Q1 2014$37,000
+117.6%
19,823
+141.7%
0.00%
Q4 2013$17,000
-93.3%
8,200
-91.5%
0.00%
Q3 2013$255,000
+507.1%
96,269
+509.0%
0.00%
Q2 2013$42,00015,8070.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2017
NameSharesValueWeighting ↓
Sowell Financial Services LLC 1,507,457$593,0000.17%
Harel Insurance Investments & Financial Services Ltd. 780,000$398,0000.03%
Spark Investment Management LLC 353,400$180,0000.01%
LifePlan Financial Group, Inc 28,810$15,0000.01%
Greenwich Wealth Management LLC 60,066$31,0000.01%
SHINE INVESTMENT ADVISORY SERVICES INC 19,608$10,0000.01%
Virtu KCG Holdings LLC 336,414$172,0000.01%
LYNCH & ASSOCIATES/IN 18,000$9,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$331,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 377,875$193,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders